Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Revenue

Niagen Bioscience had revenue of $33.99M in the quarter ending September 30, 2025, with 32.86% growth. This brings the company's revenue in the last twelve months to $124.71M, up 36.04% year-over-year. In the year 2024, Niagen Bioscience had annual revenue of $99.60M with 19.18% growth.

• Revenue (ttm): $124.71M
• Revenue Growth: +36.04%
• P/S Ratio: 4.33
• Revenue / Employee: $1,199,125
• Employees: 104
• Market Cap: 551.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	99.60M	16.03M	19.18%
Dec 31, 2023	83.57M	11.52M	15.99%
Dec 31, 2022	72.05M	4.60M	6.82%
Dec 31, 2021	67.45M	8.19M	13.82%
Dec 31, 2020	59.26M	12.97M	28.01%